Back to Results
First PageMeta Content
Toxicology / Euphoriants / Organosulfate / Toxic Substances Control Act / Sodium compounds


8EHQ-11-06351B TSCA 8(e) Notice
Add to Reading List

Document Date: 2012-07-24 13:58:47


Open Document

File Size: 2,30 MB

Share Result on Facebook

City

Gamble Plaza Cincinnati / Cincinnati / /

Company

The Procter & Gamble Company / Quarterly Journal Pharm / Development Corporation / Procter 4 Gamble Company / InternationalResearch & Development Corporation / Charles River Breeding Laboratories Inc. / /

Currency

pence / USD / /

/

Event

FDA Phase / /

Facility

Plaza Cincinnati / Procter & Gamble Company NA Regulatory &Technical Relations One Procter & Gamble Plaza / /

IndustryTerm

chemical identity / submission containing g4eneic chemical / chemical constituents / /

MedicalCondition

ataxia / hyperemia / diarrhea / /

Organization

B.S. Unit / Toxics Document Control Office / EPA office of Pollution Prevention / Toxic 8uostanceti I*IYvi~ tat* Protection Agency / Wshington / Environmental Protection Agency / /

Person

Ward R. Richter / Richard H. Hall / Daniel Rajasekaran / /

/

Position

Swedan Staff Pathologist / rector / Manager The Procter & Gamble Company One Procter & Gamble Plaza Cincinnati / Coordinator / TSCA Declassification Coordinator / Associate Director / Toxicology Division Date4 STUDY DIRECTOR / DIRECTOR STATEMENT The ne'hods / Group Supervisor / A.C.V.P. Director / Pathology Division / Technical Relations Manager / Manager Regulatory / /

Product

Study / P1165 / /

ProvinceOrState

Ohio / /

RadioStation

1 FM / /

Technology

attached protocol / /

SocialTag